MODERN DIAGNOSTIC METHODS USED IN DETECTION OF CYTOMEGALOVIRUS

Abstract Human cytomegalovirus (HCMV), a betaherpes virus, is a major cause of birth defects and an important pathogen in immunocompromised individuals. Clinical symptoms may appear after initial infection, reinfection, or reactivation. Human cytomegalovirus (HCMV) usually does not cause obvious symptoms. Modern diagnostic methods indicate that HCMV is a widespread opportunistic infection in fetuses, bone marrow transplant patients, and AIDS patients. In this article, we will review the diagnostic methods used for cytomeqalovirus.References: 1. Landolfo, S., Gariglio, M., Gribaudo, G., & Lembo, D. (2003). The human cytomegalovirus. Pharmacology & therapeutics, 98(3), 269-297. 2. Rubin, R. H. (1989). The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. Jama, 261(24), 3607-3609. 3. R Schleiss, M. (2011). Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 11(5), 449-465. 4. Razonable, R. R., & Humar, A. (2019). Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clinical transplantation, 33(9), e13512. 5. Beam, E., Germer, J. J., Lahr, B., Yao, J. D., Limper, A. H., Binnicker, M. J., & Razonable, R. R. (2018). Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clinical Transplantation, 32(1), e13149. 6. Emery, V. C., & Lazzarotto, T. (2017). Cytomegalovirus in pregnancy and the neonate. F1000Research, 6. 7. de Vries, J. J., van Zwet, E. W., Dekker, F. W., Kroes, A. C., Verkerk, P. H., & Vossen, A. C. (2013). The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population‐based prediction model. Reviews in medical virology, 23(4), 241-249. 8. Revello, M. G., Tibaldi, C., Masuelli, G., Frisina, V., Sacchi, A., Furione, M., ... & Todros, T. (2015). Prevention of primary cytomegalovirus infection in pregnancy. EBioMedicine, 2(9), 1205-1210. 9. Rawlinson, W. D., Boppana, S. B., Fowler, K. B., Kimberlin, D. W., Lazzarotto, T., Alain, S., ... & van Zuylen, W. J. (2017). Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. The Lancet Infectious Diseases, 17(6), e177-e188. 10. Talking with pregnant patients about CMV: Resource for healthcare providers. (n.d.). March 13, 2023. 11. Razonable, R. R., Inoue, N., Pinninti, S. G., Boppana, S. B., Lazzarotto, T., Gabrielli, L., ... & Schmid, D. S. (2020). Clinical diagnostic testing for human cytomegalovirus infections. The Journal of infectious diseases, 221(Supplement_1), S74-S85. 12. Leruez-Ville, M., & Ville, Y. (2017). Fetal cytomegalovirus infection. Best practice & research Clinical obstetrics & gynaecology, 38, 97-107. 13. Delforge, M. L., Costa, E., Brancart, F., Goldman, D., Montesinos, I., Zaytouni, S., ... & Donner, C. (2017). Presence of cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection. Journal of Clinical Virology, 90, 14-17. 14. Tanimura, K., Tairaku, S., Ebina, Y., Morioka, I., Nagamata, S., Deguchi, K., ... & Yamada, H. (2017). Prediction of congenital cytomegalovirus infection in high-risk pregnant women. Clinical Infectious Diseases, 64(2), 159-165. 15. Lazzarotto, T., Guerra, B., Gabrielli, L., Lanari, M., & Landini, M. P. (2011). Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clinical Microbiology and Infection, 17(9), 1285-1293. 16. Enders, M., Daiminger, A., Exler, S., & Enders, G. (2017). Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks' threshold. Prenatal diagnosis, 37(9), 940-942. 17. Bringman, J. J. (2014). Invasive prenatal genetic testing: A Catholic healthcare provider's perspective. The Linacre Quarterly, 81(4), 302-313. 18. Leruez-Ville, M., Stirnemann, J., Sellier, Y., Guilleminot, T., Dejean, A., Magny, J. F., ... & Ville, Y. (2016). Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. American journal of obstetrics and gynecology, 215(3), 342-e1. 19. Chen, Y., Wu, Z., Sutlive, J., Wu, K., Mao, L., Nie, J., ... & Huang, Q. (2022). Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells. Journal of Nanobiotechnology, 20(1), 546. 20. Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F, Ayoubi JM, Grangeot Keros L, Benachi A. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn. 2013 Aug;33(8):751-8. 21. Capretti, M. G., Lanari, M., Tani, G., Ancora, G., Sciutti, R., Marsico, C., ... & Faldella, G. (2014). Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection. Brain and Development, 36(3), 203-211. 22. Wirgart, B. Z., & Grillner, L. (1986). Early detection of cytomegalovirus in cell culture by a monoclonal antibody. Journal of virological methods, 14(1), 65-69. 23. Eventov-Friedman, S., Manor, H., Bar-Oz, B., Averbuch, D., Caplan, O., Lifshitz, A., ... & Wolf, D. G. (2019). Saliva real-time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection. The Journal of Infectious Diseases, 220(11), 1790-1796